Artemis Medicare Services Receives 'Hold' Rating

Artemis Medicare Services, a smallcap healthcare services company, has recently received a 'Hold' rating from MarketsMOJO on December 18, 2023. This downgrade comes as the company has shown healthy long-term growth with an annual operating profit increase of 66.91%. In addition, the company has also reported positive results in September 2023, with its operating cash flow at its highest at Rs 127.16 crore and return on capital employed at 11.34%. Its PBDIT for the quarter was also at its highest at Rs 34.21 crore. Technically, the stock is currently in a mildly bullish range, with multiple factors such as MACD, Bollinger Band, KST, and OBV indicating a bullish trend. Furthermore, with a ROCE of 11.2, the stock is considered to have an attractive valuation with a 3.8 enterprise value to capital employed. Despite its strong performance, the stock is currently trading at a discount compared to its average historical valuations. In the past year, the stock has generated a return of 120.17%, while its profits have increased by 19.2%. However, the PEG ratio of the company is at 3.1, indicating a slightly overvalued stock. Artemis Medicare Services has also shown consistent returns over the last three years, outperforming the BSE 500 index in each of the last three annual periods. However, despite its potential, domestic mutual funds hold only 0.23% of the company, which could signify their discomfort with the current price or the business itself. As a smallcap company, it is important for investors to conduct thorough research before making any investment decisions.